International immunosuppression & Transplant Skin Cancer Collaborative (ITSCC)

The International immunosuppression & Transplant Skin Cancer Collaborative (ITSCC) is an organization of dermatologic surgeons, clinicians and researchers from multiple disciplines dedicated to advancing the care and understanding of skin cancer in organ transplant recipients.

These patients are up to 65 times more likely to develop skin cancer than people without transplants. Skin cancer is the most common cancer affecting solid organ transplant recipients, affecting up to 70 percent of patients within 20 years, and is the result of intense immunosuppressive regimens.

Mission:
• To integrate and support basic scientific and clinical research to address the special needs of immunosuppressed patients and organ transplant recipients with skin cancer in order to improve quality of care.
• To educate patients, scientists, primary care doctors and specialist physicians on the unique needs and clinical care issues in immunosuppressed and transplant patients.